Skip to search formSkip to main contentSkip to account menu

Verum

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
RETRACTED ARTICLE: Bright light treatment as mono-therapy of non-seasonal depression for 28 adolescents
We, the Editors and Publisher of the International Journal of Psychiatry in Clinical Practice, have retracted the following… 
2012
2012
Randomized sham‐controlled trial of acupuncture for postoperative pain control after stapled haemorrhoidopexy
Aim  Haemorrhoidectomy usually causes moderate to strong postoperative pain. Chinese studies have found that acupuncture may have… 
2007
2007
Fumigant activity of essential oils and components of Illicium verum and Schizonepeta tenuifolia against Botrytis cinerea and Colletotrichum gloeosporioides.
To develop a natural fungicide against Botrytis cinerea and Colletotrichum gloeosporioides, a total of 25 essential oils were… 
2007
2007
Neural correlates of transmeatal cochlear laser (TCL) stimulation in healthy human subjects
2007
2007
Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
2006
2006
Double-blind, placebo-controlled homeopathic pathogenetic trials: Symptom collection and analysis
2003
2003
Effects of homeopathic treatment on pruritus of haemodialysis patients: a randomised placebo-controlled double-blind trial
1995
1995
Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease.
Highly Cited
1993
Highly Cited
1993
[Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study].
The efficacy of a Vitex agnus castus preparation (Strotan capsules) was investigated in a randomized double blind study vs… 
Review
1989
Review
1989
Gerontopsychological studies using NAI ('Nürnberger Alters-Inventar') on patients with organic psychosyndrome (DSM III, Category 1) treated with centrophenoxine in a double blind, comparative…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)